Vifor Fresenius Medical Care Renal Pharma

Quick facts

Phase 3 pipeline

• Difelikefalin Injection · Nephrology
  Difelikefalin is a selective agonist of the peripheral kinin B1 receptor that reduces pruritus by modulating inflammatory pathways in patients with chronic kidney disease.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vifor Fresenius Medical Care Renal Pharma portfolio CI brief
• Vifor Fresenius Medical Care Renal Pharma pipeline updates RSS